Category: Uncategorized

CIPO unveils our new name and brand, ImmUnity Canada

by Whitney

As we celebrate our 25th anniversary, we are thrilled to announce that the Canadian Immunodeficiencies Patient Organization (CIPO) is rebranding to ImmUnity Canada.  What to expect: Updates to our name and brand will roll out over the coming weeks. There will be no changes to the quality of services and programs we provide. We will…



Update on Canadian Blood Services News

by Whitney

In response to recent news items, we would like to state that regarding the rumours of Canadian Blood Services and the possibility of the announcement of an impending deal with a plasma manufacturer: The Canadian Immunodeficiencies Patient Organization (CIPO), supports CBS and any efforts to increase Canada’s plasma supply including any public/private partnership. If CBS…



New CIPO Strategic Plan

by Whitney

CIPO has been undergoing a strategic planning exercise and are happy to announce our new Strategic Plan 2022-2027. Our goals and objectives for the next three to five years will focus on sustainability, strong programming, community-building and advocacy. We also have a new mission, vision and values to better serve the immunodeficiency population in Canada. …



New Research Opportunities

by Whitney

Three research studies are currently recruiting from members of the immunodeficiency community. Please see below for more details: Primary immunodeficiency patients who have been diagnosed with IgA sensitivity may be eligible to take part in a study being conducted by Ipsos on behalf of a pharmaceutical company. Please contact Julie Kanhnha 1-866-711-5948 for more information. Families with children…



CIPO AGM and Board Elections

by Whitney

AGM The Canadian Immunodeficiencies Patient Organization (CIPO) 2022 Annual General Meeting will take place virtually Saturday, October 1st at 4pm EST (1pm PST). All CIPO members are entitled to attend and vote at the AGM. Please register your intention to attend the AGM HERE.  The AGM agenda will be circulated closer to the date.  BOARD ELECTIONS – CALL FOR NOMINEES The Canadian Immunodeficiencies Patient Organization (CIPO)…



New CIPO Bylaws

by Whitney

CIPO‘s Board of Directors and Governance Committee have reviewed and re-drafted the organizational bylaws given the input from our membership. The bylaws will be voted on at the AGM on October 1, 2022. Please send any comments or questions to info@cipo.ca Final Draft – CIPO By-laws 2021 (1)



CIPO Scholarship Awards Open

by Whitney

CIPO is excited to announce the first ever higher education scholarship application open.  These scholarships are open to youth 17-25 who are currently enrolled or accepted at a recognized Canadian higher education institution and whose lives have been impacted by immunodeficiency.  For full details and application guidelines: CIPO Youth Higher Education Scholarship Deadline: June 30th, 2022



CIPO Immunology Resident Research Grant applications open

by Whitney

CIPO is pleased applications are now open for the CIPO Immunology Resident Research Grant in honour of our 25th anniversary. Up to two residents will be awarded, pending the complexity of proposed study. The maximum award pool is $10,000. Submission Deadline: All applications are due to be submitted to the following e-mail address: whitney.goulstone@cipo.ca by…



CIPO Study Published

by Whitney

CIPO’s COVID-19 study that looked at vaccine hestitancy in PI patients has been published in the journal for Allergy, Asthma and Immunology. We are pleased to have supported this research and be taking part in important developments in the primary immunodeficiency community.  The article, “Understanding attitudes and obstacles to vaccination against COVID-19 in patients with…



CIPO COVID Q&A Webinar

by Whitney

May 10th, CIPO held another COVID Q&A webinar with two of our medical directors: Dr. Bruce Ritchie and Dr. Kyla Hildebrand. You can watch this webinar at our YouTube channel here: https://youtu.be/LJumbWkM6GY Thank you to everyone who submitted questions. We will be holding another COVID session at our conference in September.